APY0201

CAS : 1232221-74-7

Ref. 3D-BA177440

Informations sur le produit

• Nom: APY0201
• CAS: 1232221-74-7

Description

APY0201 is a biological product that is used to treat autoimmune diseases. It is a cell-based therapy that has been shown to have cytotoxic effects on target tissues, including cancerous tissues and virus-infected cells. The product is administered orally and its effective dose is dependent on the localisation of the cells in the body and their sensitivity to APY0201. APY0201 has been shown to be effective against eye disorders such as uveitis, optic neuritis, and glaucoma. This drug can be applied at nanomolar concentrations for localized delivery of therapeutics for these conditions.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 413.48 g/mol
• Formule: C₂₃H₂₃N₇O
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C23H23N7O/c1-17-3-2-4-18(13-17)16-25-27-21-15-23(29-9-11-31-12-10-29)30-22(26-21)14-20(28-30)19-5-7-24-8-6-19/h2-8,13-16H,9-12H2,1H3,(H,26,27)/b25-16+
• Code InChI: InChIKey=RFZQYGBLRIKROZ-PCLIKHOPSA-N
• SMILES: Cc1cccc(/C=N/Nc2cc(N3CCOCC3)n3nc(-c4ccncc4)cc3n2)c1